The rapid and effective suppression of GO-pathogenic CD4+ CTLs makes it one of the main mechanisms underlying the remarkable efficacy of rapamycin in GO, although Th1 cells, Th17 cells, and Tregs are also reportedly potential targets (28). This evidence concerns the gene CD4 and geroderma osteodysplastica.